Superdisintegrants Market by Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin), Formulation (Tablet, Capsules), Therapeutic Area (Gastrointestinal, Cardiovascular, Neurology, Oncology, Hematology) - Global Forecast to 2023
“The global superdisintegrants market is projected to grow at a CAGR of 7.9%.”
The superdisintegrants market is expected to reach USD 536.5 million by 2023 from an estimated USD 366.4 million in 2018, at a CAGR of 7.9%. The increasing adoption of orally disintegrating tablets, growing generics market, and emergence of new superdisintegrants for the pharmaceutical industry are the factors driving the market for superdisintegrants. The shifting focus of pharmaceutical manufacturing to emerging markets and the growth of the overall pharmaceutical sector in these markets present significant opportunities for the superdisintegrants market growth. However, safety and quality concerns are expected to challenge the growth of the superdisintegrants market to a certain extent during the forecast period.
“The synthetic superdisintegrants segment is expected to register the highest CAGR during the forecast period.”
By type, the superdisintegrants market is segmented into natural superdisintegrants, synthetic superdisintegrants, and other superdisintegrants. The synthetic superdisintegrants segment is further subsegmented into modified starch, cross-linked polyvinylpyrrolidone (crospovidone), modified cellulose, ion exchange resins, and calcium silicates. The synthetic superdisintegrants segment is expected to register the highest CAGR during the forecast period. This growth can be attributed to the widespread use of these superdisintegrants in various oral drug formulations, especially in orally disintegrating tablets.
“Tablet formulation segment is expected to witness the highest growth during the forecast period.”
By formulation, the superdisintegrants market is segmented into tablets and capsules. The tablets segment is expected to witness the highest CAGR owing to the widespread use of orally disintegrating tablets (ODT) and fast-disintegrating tablets among healthcare providers and patients driven by the advantages such as increasing drug bioavailability, better pregastric absorption, ease of swallowing in patients with dysphagia, ease of administration, and improved shelf life.
“APAC superdisintegrants market is projected to witness the highest growth during the forecast period.”
Europe held the largest share of the global superdisintegrants market in 2017. On the other hand, the APAC superdisintegrants market is expected to witness the highest CAGR during the forecast period, owing to the significant growth in pharmaceutical manufacturing in the past few years, low-cost manufacturing advantage, increasing per capita income, low regulatory stringency, and growing interest of key players in APAC countries.
Break of primary participants was as mentioned below:
Research Coverage:
The report analyzes the various superdisintegrants products and their adoption pattern. It aims at estimating the market size and future growth potential of the global superdisintegrants market for different segments by type, formulation, therapeutic area, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening the market.
This report provides insights on the following pointers:
The superdisintegrants market is expected to reach USD 536.5 million by 2023 from an estimated USD 366.4 million in 2018, at a CAGR of 7.9%. The increasing adoption of orally disintegrating tablets, growing generics market, and emergence of new superdisintegrants for the pharmaceutical industry are the factors driving the market for superdisintegrants. The shifting focus of pharmaceutical manufacturing to emerging markets and the growth of the overall pharmaceutical sector in these markets present significant opportunities for the superdisintegrants market growth. However, safety and quality concerns are expected to challenge the growth of the superdisintegrants market to a certain extent during the forecast period.
“The synthetic superdisintegrants segment is expected to register the highest CAGR during the forecast period.”
By type, the superdisintegrants market is segmented into natural superdisintegrants, synthetic superdisintegrants, and other superdisintegrants. The synthetic superdisintegrants segment is further subsegmented into modified starch, cross-linked polyvinylpyrrolidone (crospovidone), modified cellulose, ion exchange resins, and calcium silicates. The synthetic superdisintegrants segment is expected to register the highest CAGR during the forecast period. This growth can be attributed to the widespread use of these superdisintegrants in various oral drug formulations, especially in orally disintegrating tablets.
“Tablet formulation segment is expected to witness the highest growth during the forecast period.”
By formulation, the superdisintegrants market is segmented into tablets and capsules. The tablets segment is expected to witness the highest CAGR owing to the widespread use of orally disintegrating tablets (ODT) and fast-disintegrating tablets among healthcare providers and patients driven by the advantages such as increasing drug bioavailability, better pregastric absorption, ease of swallowing in patients with dysphagia, ease of administration, and improved shelf life.
“APAC superdisintegrants market is projected to witness the highest growth during the forecast period.”
Europe held the largest share of the global superdisintegrants market in 2017. On the other hand, the APAC superdisintegrants market is expected to witness the highest CAGR during the forecast period, owing to the significant growth in pharmaceutical manufacturing in the past few years, low-cost manufacturing advantage, increasing per capita income, low regulatory stringency, and growing interest of key players in APAC countries.
Break of primary participants was as mentioned below:
- By Company Type: Tier 1–48%, Tier 2–34% and Tier 3–18%
- By Designation: C-level–42%, Director Level–40%, Others–18%
- By Region: North America–38%, Europe–32%, Asia Pacific–21%, Latin America–6%, Middle East & Africa–3%
Research Coverage:
The report analyzes the various superdisintegrants products and their adoption pattern. It aims at estimating the market size and future growth potential of the global superdisintegrants market for different segments by type, formulation, therapeutic area, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening the market.
This report provides insights on the following pointers:
- Market Penetration: Comprehensive information on product portfolios offered by the top players in the global superdisintegrants market
- Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and product launches in the global superdisintegrants market
- Market Development: Comprehensive information on the lucrative and emerging market
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global superdisintegrants market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the global superdisintegrants market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key data from primary sources
2.1.2.2 Break down of primaries
2.1.2.3 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 DATA TRIANGULATION APPROACH
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 SUPERDISINTEGRANTS MARKET OVERVIEW
4.2 SUPERDISINTEGRANTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.3 REGIONAL MIX: SUPERDISINTEGRANTS MARKET (2018–2023)
4.4 SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE AND REGION (2017)
4.5 SUPERDISINTEGRANTS MARKET: DEVELOPED VS. DEVELOPING MARKETS, 2018 VS 2023
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 MARKET DRIVERS
5.2.1.1 Growing adoption of orally disintegrating tablets
5.2.1.2 Growing generics market
5.2.1.3 Emergence of new superdisintegrants for the pharmaceutical industry
5.2.2 MARKET OPPORTUNITIES
5.2.2.1 Pharmaceutical market expansion in emerging countries
5.2.3 MARKET CHALLENGES
5.2.3.1 Safety and quality concerns
6 REGULATORY ANALYSIS
6.1 INTRODUCTION
6.2 NORTH AMERICA
6.2.1 US
6.2.2 CANADA
6.3 EUROPE
6.4 ASIA PACIFIC
6.4.1 JAPAN
6.4.2 CHINA
6.4.3 INDIA
7 SUPERDISINTEGRANTS MARKET, BY TYPE
7.1 INTRODUCTION
7.2 SYNTHETIC SUPERDISINTEGRANTS
7.2.1 CROSPOVIDONE
7.2.2 MODIFIED STARCH (SODIUM STARCH GLYCOLATE)
7.2.3 MODIFIED CELLULOSE
7.2.3.1 Croscarmellose sodium
7.2.3.2 Low-substituted hydroxypropyl cellulose
7.2.4 CALCIUM SILICATES
7.2.5 ION EXCHANGE RESINS
7.3 NATURAL SUPERDISINTEGRANTS
7.4 OTHER SUPERDISINTEGRANTS
8 SUPERDISINTEGRANTS MARKET, BY FORMULATION
8.1 INTRODUCTION
8.2 TABLETS
8.3 CAPSULES
9 SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA
9.1 INTRODUCTION
9.2 NEUROLOGICAL DISEASES
9.3 GASTROINTESTINAL DISEASES
9.4 ONCOLOGY
9.5 INFLAMMATORY DISEASES
9.6 INFECTIOUS DISEASES
9.7 CARDIOVASCULAR DISEASES
9.8 HEMATOLOGICAL DISEASES
10 SUPERDISINTEGRANTS MARKET, BY REGION
10.1 INTRODUCTION
10.2 EUROPE
10.2.1 SWITZERLAND
10.2.2 GERMANY
10.2.3 ITALY
10.2.4 FRANCE
10.2.5 UK
10.2.6 SPAIN
10.2.7 REST OF EUROPE
10.3 NORTH AMERICA
10.3.1 US
10.3.2 CANADA
10.4 ASIA PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 COMPETITIVE SITUATION AND TRENDS
11.3 MARKET SHARE ANALYSIS
12 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
12.1 BASF SE
12.2 ASHLAND GLOBAL HOLDINGS INC.
12.3 DOWDUPONT INC.
12.4 ROQUETTE FRERES
12.5 DFE PHARMA
12.6 JRS PHARMA
12.7 ASAHI KASEI CORPORATION
12.8 MERCK KGAA
12.9 COREL PHARMA CHEM
12.10 AVANTOR PERFORMANCE MATERIALS, LLC
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
13 APPENDIX
13.1 INSIGHTS OF INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key data from primary sources
2.1.2.2 Break down of primaries
2.1.2.3 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 DATA TRIANGULATION APPROACH
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 SUPERDISINTEGRANTS MARKET OVERVIEW
4.2 SUPERDISINTEGRANTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.3 REGIONAL MIX: SUPERDISINTEGRANTS MARKET (2018–2023)
4.4 SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE AND REGION (2017)
4.5 SUPERDISINTEGRANTS MARKET: DEVELOPED VS. DEVELOPING MARKETS, 2018 VS 2023
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 MARKET DRIVERS
5.2.1.1 Growing adoption of orally disintegrating tablets
5.2.1.2 Growing generics market
5.2.1.3 Emergence of new superdisintegrants for the pharmaceutical industry
5.2.2 MARKET OPPORTUNITIES
5.2.2.1 Pharmaceutical market expansion in emerging countries
5.2.3 MARKET CHALLENGES
5.2.3.1 Safety and quality concerns
6 REGULATORY ANALYSIS
6.1 INTRODUCTION
6.2 NORTH AMERICA
6.2.1 US
6.2.2 CANADA
6.3 EUROPE
6.4 ASIA PACIFIC
6.4.1 JAPAN
6.4.2 CHINA
6.4.3 INDIA
7 SUPERDISINTEGRANTS MARKET, BY TYPE
7.1 INTRODUCTION
7.2 SYNTHETIC SUPERDISINTEGRANTS
7.2.1 CROSPOVIDONE
7.2.2 MODIFIED STARCH (SODIUM STARCH GLYCOLATE)
7.2.3 MODIFIED CELLULOSE
7.2.3.1 Croscarmellose sodium
7.2.3.2 Low-substituted hydroxypropyl cellulose
7.2.4 CALCIUM SILICATES
7.2.5 ION EXCHANGE RESINS
7.3 NATURAL SUPERDISINTEGRANTS
7.4 OTHER SUPERDISINTEGRANTS
8 SUPERDISINTEGRANTS MARKET, BY FORMULATION
8.1 INTRODUCTION
8.2 TABLETS
8.3 CAPSULES
9 SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA
9.1 INTRODUCTION
9.2 NEUROLOGICAL DISEASES
9.3 GASTROINTESTINAL DISEASES
9.4 ONCOLOGY
9.5 INFLAMMATORY DISEASES
9.6 INFECTIOUS DISEASES
9.7 CARDIOVASCULAR DISEASES
9.8 HEMATOLOGICAL DISEASES
10 SUPERDISINTEGRANTS MARKET, BY REGION
10.1 INTRODUCTION
10.2 EUROPE
10.2.1 SWITZERLAND
10.2.2 GERMANY
10.2.3 ITALY
10.2.4 FRANCE
10.2.5 UK
10.2.6 SPAIN
10.2.7 REST OF EUROPE
10.3 NORTH AMERICA
10.3.1 US
10.3.2 CANADA
10.4 ASIA PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 COMPETITIVE SITUATION AND TRENDS
11.3 MARKET SHARE ANALYSIS
12 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
12.1 BASF SE
12.2 ASHLAND GLOBAL HOLDINGS INC.
12.3 DOWDUPONT INC.
12.4 ROQUETTE FRERES
12.5 DFE PHARMA
12.6 JRS PHARMA
12.7 ASAHI KASEI CORPORATION
12.8 MERCK KGAA
12.9 COREL PHARMA CHEM
12.10 AVANTOR PERFORMANCE MATERIALS, LLC
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
13 APPENDIX
13.1 INSIGHTS OF INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS
LIST OF TABLES
Table 1 INCREASE IN GERIATRIC POPULATION ACROSS THE GLOBE
Table 2 DRUGS FACING PATENT EXPIRY
Table 3 KEY MARKET DRIVERS: IMPACT ANALYSIS
Table 4 KEY MARKET OPPORTUNITIES: IMPACT ANALYSIS
Table 5 KEY MARKET CHALLENGES: IMPACT ANALYSIS
Table 6 SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 7 SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 8 SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 9 SYNTHETIC SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 10 CROSPOVIDONE SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 11 MODIFIED STARCH SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 12 MODIFIED CELLULOSE SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 13 MODIFIED CELLULOSE SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 14 CROSCARMELLOSE SODIUM SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 15 LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 16 CALCIUM SILICATES SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 17 ION EXCHANGE RESINS SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 18 NATURAL SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 19 OTHER SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 20 SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 21 SUPERDISINTEGRANTS MARKET FOR TABLETS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 22 SUPERDISINTEGRANTS MARKET FOR CAPSULES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 23 SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 24 SUPERDISINTEGRANTS MARKET FOR NEUROLOGICAL DISEASES, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 25 SUPERDISINTEGRANTS MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 26 SUPERDISINTEGRANTS MARKET FOR ONCOLOGY, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 27 SUPERDISINTEGRANTS MARKET FOR INFLAMMATORY DISEASES, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 28 SUPERDISINTEGRANTS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 29 SUPERDISINTEGRANTS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 30 SUPERDISINTEGRANTS MARKET FOR HEMATOLOGICAL DISEASES, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 31 SUPERDISINTEGRANTS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 32 EUROPE: SUPERDISINTEGRANTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 33 EUROPE: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 34 EUROPE: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 35 EUROPE: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 36 EUROPE: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 37 EUROPE: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 38 SWITZERLAND: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 39 SWITZERLAND: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 40 SWITZERLAND: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 41 SWITZERLAND: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 42 SWITZERLAND: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 43 GERMANY: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 44 GERMANY: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 45 GERMANY: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 46 GERMANY: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 47 GERMANY: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 48 ITALY: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 49 ITALY: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 50 ITALY: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 51 ITALY: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 52 ITALY: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 53 FRANCE: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 54 FRANCE: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 55 FRANCE: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 56 FRANCE: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 57 FRANCE: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 58 UK: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 59 UK: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 60 UK: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 61 UK: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 62 UK: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 63 SPAIN: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 64 SPAIN: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 65 SPAIN: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 66 SPAIN: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 67 SPAIN: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 68 ROE: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 69 ROE: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 70 ROE: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 71 ROE: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 72 ROE: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 73 NORTH AMERICA: SUPERDISINTEGRANTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 74 NORTH AMERICA: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 75 NORTH AMERICA: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 76 NORTH AMERICA: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 77 NORTH AMERICA: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 78 NORTH AMERICA: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 79 US: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 80 US: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 81 US: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 82 US: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 83 US: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 84 CANADA: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 85 CANADA: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 86 CANADA: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 87 CANADA: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 88 CANADA: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 89 ASIA PACIFIC: SUPERDISINTEGRANTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 90 ASIA PACIFIC: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 91 ASIA PACIFIC: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 92 ASIA PACIFIC: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 93 ASIA PACIFIC: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 94 ASIA PACIFIC: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 95 JAPAN: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 96 JAPAN: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 97 JAPAN: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 98 JAPAN: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 99 JAPAN: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 100 CHINA: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 101 CHINA: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 102 CHINA: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 103 CHINA: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 104 CHINA: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 105 INDIA: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 106 INDIA: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 107 INDIA: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 108 INDIA: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 109 INDIA: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 110 ROAPAC: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 111 ROAPAC: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 112 ROAPAC: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 113 ROAPAC: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 114 ROAPAC: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 115 LATIN AMERICA: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 116 LATIN AMERICA: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 117 LATIN AMERICA: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 118 LATIN AMERICA: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 119 LATIN AMERICA: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 120 MIDDLE EAST & AFRICA: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 121 MIDDLE EAST & AFRICA: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 122 MIDDLE EAST & AFRICA: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 123 MIDDLE EAST & AFRICA: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 124 MIDDLE EAST & AFRICA: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 1 INCREASE IN GERIATRIC POPULATION ACROSS THE GLOBE
Table 2 DRUGS FACING PATENT EXPIRY
Table 3 KEY MARKET DRIVERS: IMPACT ANALYSIS
Table 4 KEY MARKET OPPORTUNITIES: IMPACT ANALYSIS
Table 5 KEY MARKET CHALLENGES: IMPACT ANALYSIS
Table 6 SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 7 SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 8 SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 9 SYNTHETIC SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 10 CROSPOVIDONE SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 11 MODIFIED STARCH SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 12 MODIFIED CELLULOSE SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 13 MODIFIED CELLULOSE SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 14 CROSCARMELLOSE SODIUM SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 15 LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 16 CALCIUM SILICATES SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 17 ION EXCHANGE RESINS SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 18 NATURAL SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 19 OTHER SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 20 SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 21 SUPERDISINTEGRANTS MARKET FOR TABLETS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 22 SUPERDISINTEGRANTS MARKET FOR CAPSULES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 23 SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 24 SUPERDISINTEGRANTS MARKET FOR NEUROLOGICAL DISEASES, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 25 SUPERDISINTEGRANTS MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 26 SUPERDISINTEGRANTS MARKET FOR ONCOLOGY, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 27 SUPERDISINTEGRANTS MARKET FOR INFLAMMATORY DISEASES, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 28 SUPERDISINTEGRANTS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 29 SUPERDISINTEGRANTS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 30 SUPERDISINTEGRANTS MARKET FOR HEMATOLOGICAL DISEASES, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 31 SUPERDISINTEGRANTS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 32 EUROPE: SUPERDISINTEGRANTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 33 EUROPE: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 34 EUROPE: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 35 EUROPE: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 36 EUROPE: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 37 EUROPE: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 38 SWITZERLAND: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 39 SWITZERLAND: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 40 SWITZERLAND: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 41 SWITZERLAND: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 42 SWITZERLAND: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 43 GERMANY: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 44 GERMANY: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 45 GERMANY: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 46 GERMANY: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 47 GERMANY: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 48 ITALY: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 49 ITALY: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 50 ITALY: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 51 ITALY: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 52 ITALY: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 53 FRANCE: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 54 FRANCE: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 55 FRANCE: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 56 FRANCE: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 57 FRANCE: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 58 UK: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 59 UK: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 60 UK: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 61 UK: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 62 UK: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 63 SPAIN: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 64 SPAIN: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 65 SPAIN: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 66 SPAIN: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 67 SPAIN: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 68 ROE: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 69 ROE: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 70 ROE: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 71 ROE: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 72 ROE: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 73 NORTH AMERICA: SUPERDISINTEGRANTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 74 NORTH AMERICA: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 75 NORTH AMERICA: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 76 NORTH AMERICA: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 77 NORTH AMERICA: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 78 NORTH AMERICA: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 79 US: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 80 US: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 81 US: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 82 US: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 83 US: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 84 CANADA: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 85 CANADA: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 86 CANADA: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 87 CANADA: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 88 CANADA: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 89 ASIA PACIFIC: SUPERDISINTEGRANTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 90 ASIA PACIFIC: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 91 ASIA PACIFIC: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 92 ASIA PACIFIC: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 93 ASIA PACIFIC: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 94 ASIA PACIFIC: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 95 JAPAN: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 96 JAPAN: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 97 JAPAN: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 98 JAPAN: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 99 JAPAN: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 100 CHINA: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 101 CHINA: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 102 CHINA: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 103 CHINA: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 104 CHINA: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 105 INDIA: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 106 INDIA: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 107 INDIA: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 108 INDIA: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 109 INDIA: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 110 ROAPAC: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 111 ROAPAC: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 112 ROAPAC: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 113 ROAPAC: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 114 ROAPAC: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 115 LATIN AMERICA: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 116 LATIN AMERICA: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 117 LATIN AMERICA: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 118 LATIN AMERICA: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 119 LATIN AMERICA: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
Table 120 MIDDLE EAST & AFRICA: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 121 MIDDLE EAST & AFRICA: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 122 MIDDLE EAST & AFRICA: MODIFIED CELLULOSE MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 123 MIDDLE EAST & AFRICA: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016–2023 (USD MILLION)
Table 124 MIDDLE EAST & AFRICA: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016–2023 (USD MILLION)
LIST OF FIGURES
Figure 1 SUPERDISINTEGRANTS MARKET
Figure 2 RESEARCH DESIGN
Figure 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATIONS, AND REGION
Figure 4 BOTTOM-UP APPROACH
Figure 5 TOP-DOWN APPROACH
Figure 6 DATA TRIANGULATION METHODOLOGY
Figure 7 SUPERDISINTEGRANTS MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION)
Figure 8 SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
Figure 9 SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2018 VS. 2023 (USD MILLION)
Figure 10 SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2018 VS. 2023 (USD MILLION)
Figure 11 GEOGRAPHICAL SNAPSHOT: SUPERDISINTEGRANTS MARKET
Figure 12 INCREASING ADOPTION OF ORALLY DISINTEGRATING TABLETS IS EXPECTED TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
Figure 13 US DOMINATED THE GLOBAL SUPERDISINTEGRANTS MARKET IN 2017
Figure 14 APAC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2018–2023)
Figure 15 CROSPOVIDONE ACCOUNTED FOR THE LARGEST SHARE OF THE GLOBAL SUPERDISINTEGRANTS MARKET IN 2017
Figure 16 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE BETWEEN 2018 & 2023
Figure 17 SUPERDISINTEGRANTS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
Figure 18 SYNTHETIC SUPERDISINTEGRANTS TO DOMINATE THE GLOBAL SUPERDISINTEGRANTS MARKET DURING THE FORECAST PERIOD
Figure 19 TABLETS SEGMENT TO DOMINATE THE SUPERDISINTEGRANTS MARKET DURING THE FORECAST PERIOD
Figure 20 NEUROLOGICAL DISEASES TO DOMINATE THE SUPERDISINTEGRANTS MARKET DURING 2018–2023
Figure 21 CANCER INCIDENCE ACROSS KEY COUNTRIES, 2012
Figure 22 ANNUAL NUMBER OF DEATHS DUE TO INFECTIOUS DISEASES, 2016
Figure 23 SUPERDISINTEGRANTS MARKET: GEOGRAPHIC SNAPSHOT (2017)
Figure 24 EUROPE: PHARMACEUTICAL PRODUCTION, 2015 (USD MILLION)
Figure 25 EUROPE: GENERICS MARKET (2014)
Figure 26 EUROPE: SUPERDISINTEGRANTS MARKET SNAPSHOT
Figure 27 NORTH AMERICA: SUPERDISINTEGRANTS MARKET SNAPSHOT
Figure 28 ASIA PACIFIC: SUPERDISINTEGRANTS MARKET SNAPSHOT
Figure 29 KEY DEVELOPMENTS IN THE SUPERDISINTEGRANTS MARKET FROM 2015 TO MAY 2018
Figure 30 SUPERDISINTEGRANTS MARKET SHARE, BY KEY PLAYER, 2017
Figure 31 BASF SE: COMPANY SNAPSHOT (2017)
Figure 32 ASHLAND GLOBAL HOLDINGS INC.: COMPANY SNAPSHOT (2017)
Figure 33 DOWDUPONT INC.: COMPANY SNAPSHOT (2017)
Figure 34 ROQUETTE FRERES: COMPANY SNAPSHOT (2017)
Figure 35 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2017)
Figure 36 MERCK KGAA: COMPANY SNAPSHOT (2017)
Figure 37 MARKETSANDMARKETS KNOWLEDGE STORE: HEALTHCARE INDUSTRY SNAPSHOT
Figure 1 SUPERDISINTEGRANTS MARKET
Figure 2 RESEARCH DESIGN
Figure 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATIONS, AND REGION
Figure 4 BOTTOM-UP APPROACH
Figure 5 TOP-DOWN APPROACH
Figure 6 DATA TRIANGULATION METHODOLOGY
Figure 7 SUPERDISINTEGRANTS MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION)
Figure 8 SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
Figure 9 SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2018 VS. 2023 (USD MILLION)
Figure 10 SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2018 VS. 2023 (USD MILLION)
Figure 11 GEOGRAPHICAL SNAPSHOT: SUPERDISINTEGRANTS MARKET
Figure 12 INCREASING ADOPTION OF ORALLY DISINTEGRATING TABLETS IS EXPECTED TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
Figure 13 US DOMINATED THE GLOBAL SUPERDISINTEGRANTS MARKET IN 2017
Figure 14 APAC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2018–2023)
Figure 15 CROSPOVIDONE ACCOUNTED FOR THE LARGEST SHARE OF THE GLOBAL SUPERDISINTEGRANTS MARKET IN 2017
Figure 16 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE BETWEEN 2018 & 2023
Figure 17 SUPERDISINTEGRANTS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
Figure 18 SYNTHETIC SUPERDISINTEGRANTS TO DOMINATE THE GLOBAL SUPERDISINTEGRANTS MARKET DURING THE FORECAST PERIOD
Figure 19 TABLETS SEGMENT TO DOMINATE THE SUPERDISINTEGRANTS MARKET DURING THE FORECAST PERIOD
Figure 20 NEUROLOGICAL DISEASES TO DOMINATE THE SUPERDISINTEGRANTS MARKET DURING 2018–2023
Figure 21 CANCER INCIDENCE ACROSS KEY COUNTRIES, 2012
Figure 22 ANNUAL NUMBER OF DEATHS DUE TO INFECTIOUS DISEASES, 2016
Figure 23 SUPERDISINTEGRANTS MARKET: GEOGRAPHIC SNAPSHOT (2017)
Figure 24 EUROPE: PHARMACEUTICAL PRODUCTION, 2015 (USD MILLION)
Figure 25 EUROPE: GENERICS MARKET (2014)
Figure 26 EUROPE: SUPERDISINTEGRANTS MARKET SNAPSHOT
Figure 27 NORTH AMERICA: SUPERDISINTEGRANTS MARKET SNAPSHOT
Figure 28 ASIA PACIFIC: SUPERDISINTEGRANTS MARKET SNAPSHOT
Figure 29 KEY DEVELOPMENTS IN THE SUPERDISINTEGRANTS MARKET FROM 2015 TO MAY 2018
Figure 30 SUPERDISINTEGRANTS MARKET SHARE, BY KEY PLAYER, 2017
Figure 31 BASF SE: COMPANY SNAPSHOT (2017)
Figure 32 ASHLAND GLOBAL HOLDINGS INC.: COMPANY SNAPSHOT (2017)
Figure 33 DOWDUPONT INC.: COMPANY SNAPSHOT (2017)
Figure 34 ROQUETTE FRERES: COMPANY SNAPSHOT (2017)
Figure 35 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2017)
Figure 36 MERCK KGAA: COMPANY SNAPSHOT (2017)
Figure 37 MARKETSANDMARKETS KNOWLEDGE STORE: HEALTHCARE INDUSTRY SNAPSHOT
